Growth Disorders Completed Phase 3 Trials for Somavaratan (DB12421)

Also known as: Growth Disorder

IndicationStatusPhase
DBCOND0028940 (Growth Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02339090Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGHTreatment